Evidence map›Paper›PMID 37386746›Full record

ArticleJournal of cellular and molecular medicine2023

HMSCs exosome-derived miR-199a-5p attenuates sulfur mustard-associated oxidative stress via the CAV1/NRF2 signalling pathway.

Chuchu Gong, Zhengyan Gu, Xinkang Zhang, Qingqiang Xu, Guanchao Mao, Zhipeng Pei, Wenqi Meng, Jinfeng Cen, Jihao Liu, Xiaowen He and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Caveolin-1 modulates cisplatin sensitivity in oral squamous cell carcinoma through ferroptosis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Chuchu GongLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Zhengyan GuBasic Medical Center for Pulmonary Disease, Naval Medical University, Shanghai, People's Republic of China.
Xinkang ZhangLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0003-0422-5453
Qingqiang XuLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Guanchao MaoLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Zhipeng PeiLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Wenqi MengLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Jinfeng CenLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Jihao LiuLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Xiaowen HeOrigincell Technology Group Co., Ltd., Shanghai, People's Republic of China.
Mingxue SunLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Kai XiaoLab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0002-5498-9104
Naval Medical Research Command · USOriginWater (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfur mustard (SM) is a blister-producing chemical warfare agent which could lead to a cascade of systemic damage, especially severe acute lung injury. Oxidative stress is considered to be vital processes for the SM toxicity mechanism. We previously proved the therapeutic effect of exosomes derived from bone marrow mesenchymal stromal cells in promoting the repair of alveolar epithelial barrier and inhibiting apoptosis. However, the key functional components in exosomes and the underlying mechanisms have not been fully elaborated. This research shed light on the function of the key components of human umbilical cord mesenchymal stem cell-derived exosomes (HMSCs-Ex). We noted that HMSCs-Ex-derived miR-199a-5p played a vital role in reducing pneumonocyte oxidative stress and apoptosis by reducing reactive oxygen species, lipid peroxidation products and increasing the activities of antioxidant enzymes in BEAS-2B cells and mouse models after exposure to SM for 24 h. Furthermore, we demonstrated that the overexpression of miR-199a-5p in HMSCs-Ex treatment induced a further decrease of Caveolin1 and the activation of the mRNA and protein level of NRF2, HO1 and NQO1, compared with HMSCs-Ex administration. In summary, miR-199a-5p was one of the key molecules in HMSCs-Ex that attenuated SM-associated oxidative stress via regulating CAV1/NRF2 signalling pathway.

Indexed as

ExosomesMesenchymal Stem CellsMicroRNAsMustard GasAnimalsHumansMiceNF-E2-Related Factor 2Oxidative StressMicroRNAsmirn199 microRNA, humanMustard GasNF-E2-Related Factor 2acute lung injuryexosomeshuman umbilical cord mesenchymal stem cellsmiRNA-199a-5poxidative stresssulfur mustard

Identifiers

PMID37386746
PMCPMC10399537
OpenAlexW4382632249

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.